TCL Archive Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available January 5, 1990
TCL Archive Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors. October 26, 2001
TCL Archive In Brief: ACCC Annual Meeting Scheduled March 16-19; Lao to Head Pharmacology At Pittsburgh January 1, 1988
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
